Medpage Today on MSN
Older Kidney Transplant Patients Still See Benefits With Low-Dose Immunosuppression
HOUSTON -- Rate of successful kidney transplantation was similar in adults, ages 65 and older, who received a lower dose ...
The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...
Discover why Greenfire Resources offers long-term value despite dilution fears—robust Q3 results, growth plans, and ...
Due to the hectic and stressful lifestyles most people have these days, having high uric acid levels has become a common ...
News-Medical.Net on MSN
SGLT2 inhibitors show consistent cardio-renal protection in 70,000 patients
In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two ...
We often focus on blood work for diagnostics, but urine tests hold great power mdash; sometimes uncovering things that blood alone cannot .
Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...
Travere Therapeutics, Inc., today announced new data from the Phase 3 DUPLEX Study demonstrating that patients with focal segmental glomerulosclerosis (FSGS) treated with FILSPARI® (sparsentan) were ...
According to research, more Indian women are being diagnosed with lung cancer, with rates increasing faster than men.
Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results